Therapeutic effect of colon tumor cells expressing FLT-3 ligand plus systemic IL-2 in mice with syngeneic colon cancer

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Cancer Immunology and Immunotherapy

• Publication date

  2002-01-29

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00262-001-0256-0PMID 11904730PMCID PMC11034249
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The receptor tyrosine kinase c-kit provides a critical signal for survival, expansion, and maturation of mouse natural killer cells.

  2000cited by this paper
• Potentiation of immunologic responsiveness to dendritic cell-based tumor vaccines by recombinant interleukin-2.

  2000cited by this paper
• Interleukin-2: developing additional cytokine gene therapies using fibroblasts or dendritic cells to enhance tumor immunity.

  2000cited by this paper
• Antileukemic activity of Flt3 ligand in murine leukemia.

  2000cited by this paper
• Flt3-ligand induces transient tumor regression in an ectopic treatment model of major histocompatibility complex-negative prostate cancer.

  2000cited by this paper
• Flt3 Ligand Antitumor Activity in a Murine Breast Cancer Model: A Comparison with Granulocyte-Macrophage Colony-Stimulating Factor and a Potential Mechanism of Action

  1999influential reference
• Systemic administration of interleukin 2 enhances the therapeutic efficacy of dendritic cell-based tumor vaccines.

  1999cited by this paper
• Flt3-ligand administration after radiation therapy prolongs survival in a murine model of metastatic lung cancer.

  1999cited by this paper
• Generating a T cell tumor-specific immune response in vivo: can flt3-ligand-generated dendritic cells tip the balance?

  1999cited by this paper
• Dendritic cells directly trigger NK cell functions: Cross-talk relevant in innate anti-tumor immune responses in vivo

  1999cited by this paper
• Synergistic action of fms-like tyrosine kinase 3 ligand and CD40 ligand in the induction of dendritic cells and generation of antitumor immunity in vivo.

  1999cited by this paper
• c-kit ligand and Flt3 ligand: stem/progenitor cell factors with overlapping yet distinct activities.

  1998influential reference
• Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

  1998cited by this paper
• Expansion of functional NK cells in multiple tissue compartments of mice treated with Flt3-ligand: implications for anti-cancer and anti-viral therapy.

  1998influential reference
• Dendritic cells and the control of immunity

  1998cited by this paper
• FLT3: receptor and ligand. Biology and potential clinical application.

  1998cited by this paper
• FLT3 ligand administration inhibits tumor growth in murine melanoma and lymphoma.

  1998cited by this paper
• Antitumor activity and immunotherapeutic properties of Flt3-ligand in a murine breast cancer model.

  1997cited by this paper
• Flt3 ligand induces tumor regression and antitumor immune responses in vivo

  1997cited by this paper
• FLT3 ligand induces the generation of functionally active dendritic cells in mice.

  1997cited by this paper
• The FLT3 ligand is a direct and potent stimulator of the growth of primitive and committed human CD34+ bone marrow progenitor cells in vitro.

  1996cited by this paper
• Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified

  1996cited by this paper
• Effect of flt3 ligand on the ex vivo expansion of human CD34+ hematopoietic progenitor cells.

  1995cited by this paper
• Ligand for FLT3/FLK2 receptor tyrosine kinase regulates growth of haematopoietic stem cells and is encoded by variant RNAs

  1994cited by this paper
• Therapeutic effect of a vaccinia colon oncolysate prepared with interleukin-2-gene encoded vaccinia virus studied in a syngeneic CC-36 murine colon hepatic metastasis model

  1994cited by this paper
• Molecular cloning of a ligand for the flt3/flk-2 tyrosine kinase receptor: a proliferative factor for primitive hematopoietic cells.

  1993cited by this paper
• Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response.

  1990cited by this paper
• Both Dendritic Cells and Monocytes Induce Autologous and Allogeneic T Cells Receptive to Interleukin 2

  1990cited by this paper
• Characterization of tumorigenicity, mortality, metastasis, and splenomegaly of two cultured murine colon lines.

  1981cited by this paper
• Tumor induction relationships in development of transplantable cancers of the colon in mice for chemotherapy assays, with a note on carcinogen structure.

  1975cited by this paper
• Metastases: Role of Nk Cells Flt3-ligand Administration Inhibits Liver

  year unknowninfluential reference

• An effective cytokine adjuvant vaccine induces autologous T-cell response against colon cancer in an animal model

  2016cites this paper
• Immune Reconstitution Flt 3 Ligand Enhances Thymic-Dependent and Thymic-Independent

  2013cites this paper
• Mycobacterium bovis BCG and purified protein derivative-induced reduction in the CD80 expression and the antigen up-take function of dendritic cells from patients with cervical cancer.

  2011cites this paper
• FLT3 inhibitors for the treatment of autoimmune disease

  2008cites this paper
• Immunostimulatory effect of Fms-like tyrosine kinase 3 ligand on peripheral monocyte-derived dendritic cells and natural killer cells: utilization for ovarian cancer treatment.

  2008cites this paper
• An orthotopic colon cancer model for studying the B7-H3 antitumor effect in vivo

  2006cites this paper
• Sequential activation of NKT cells and NK cells provides effective innate immunotherapy of cancer

  2005cites this paper
• Both soluble and membrane-bound forms of Flt3 ligand enhance tumor immunity following “suicide” gene therapy in a murine colon carcinoma model

  2004cites this paper
• Flt3 ligand enhances thymic-dependent and thymic-independent immune reconstitution.

  2004cites this paper
• Dendritic cells engineered to express the Flt3 ligand stimulate type I immune response, and induce enhanced cytoxic T and natural killer cell cytotoxicities and antitumor immunity

  2003cites this paper
• Adjuvant effect of a Flt3 ligand (FL) gene-transduced xenogeneic cell line in a murine colon cancer model.

  2002cites this paper
• The Journal of Experimental Medicine

  2000cites this paper